AMRN - Amarin Corporation plc

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Amarin Corporation plc

Iconic Offices, The Greenway
Block C Ardilaun Court St Stephens Green
Dublin 112-114
353 0 166 99020

IndustryDrug Manufacturers—General
Full-time employees365

Key executives

NameTitlePayExercisedYear born
Mr. Aaron D. BergInterim CEO & Pres913.7kN/A1963
Mr. Thomas Charles ReillyCFO, Sec. & Sr. VP856.49kN/A1973
Dr. Steven B. Ketchum Ph.D.Pres of R&D, Exec. VP and Chief Scientific Officer991.19kN/A1965
Dr. David Keenan Ph.D.Sr. VP of Technical OperationsN/AN/AN/A
Ms. Lisa M. DeFrancescoSr. VP of Corp. Affairs & Investor RelationsN/AN/A1980
Mr. Jordan ZwickSr. VP of Corp. Bus. Devel.N/AN/A1988
Ms. Donna PasekSr. VP of HRN/AN/AN/A
Mr. Laurent AbuafPres of Europe & Sr. VPN/AN/AN/A
Dr. Nabil AbadirSr. VP, Chief Medical Officer & Head of Global Medical AffairsN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Corporate governance

Amarin Corporation plc’s ISS governance QualityScore as of 1 May 2023 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.